Serial 98343462
Live / Applied — Second extension granted (statement of use) (as of 06 Nov 2025)
What this means for you
Not registered yet, but its 05 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98343462
- Mark type
- Design / logo
- Filed
- 05 Jan 2024
- Published for opposition
- 24 Sept 2024
- Attorney of record
- Shauna M. Wertheim
Goods and services
- Class 001 — Chemicals: Chemical products, namely, magnetic nanoparticles composed of iron oxide for use in industry and scientific research; chemical metallic and magnetic particles and nanometer particles for use in industry and scientific research; chemicals in the nature of biopolymers containing metallic nanoparticles for use in industry and scientific research; synthetic and natural oxides in the form of granules and granulates containing iron oxide in the nature of magnetite and maghemite; chemical products in the form of magnetic nanoparticles, namely, iron oxides in the nature of superparamagnetic nanoparticles and superparamagnetic iron oxide nanoparticles for use in industry and scientific research; chemical preparations in the form of biocompatible polymer nanoparticles, liposomes, coated nanoparticles, and drug-containing nanoparticles, all of the foregoing for use in industry and scientific research, namely, for use in therapy methods, thermotherapy methods, thermoablation methods and/or hyperthermia methods, but not including radiotherapy methods
- Class 005 — Pharmaceuticals: Diagnostic agents for medical purposes, diagnostic preparations for medical purposes, and pharmaceutical preparations for the treatment of malignant or benign tumor diseases, cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases containing magnetic particles, namely, magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles comprising iron oxide; pharmaceutical preparations containing metallic or magnetic particles in the nature of nanoparticles for use as anticarcinogenic agents and/or antineoplastic agents, and for treating malignant or benign tumor diseases, cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases; contrasting agents for ultrasound diagnostic imaging for medical purposes; none of the foregoing to be used with radiotherapy for cancer treatment
- Class 010 — Medical apparatus: Medical devices containing magnetic particles, namely, magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles containing iron oxide, magnetic powders, granules, and granulates containing iron oxide for providing thermotherapy, thermoablation, hyperthermia for treating malignant or benign tumor diseases, cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases, none of the foregoing devices comprising compression equipment systems or apparatus or equipment for radiotherapy
- Class 042 — Scientific and technological services: Medical and scientific research in the field of cancer and/or cardiovascular treatment and diagnosis; development and design of medical devices containing magnetic particles, namely, magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles containing iron oxide, all for treatment and/or diagnosis of cancer and/or cardiovascular diseases; providing medical testing services and scientific research information in the field of cancer and cardiovascular research; none of the foregoing services comprising radiotherapy in cancer treatment
- Class 044 — Medical, beauty and agricultural services: Medical services, namely, medical services in the nature of cancer and cardiovascular therapy, cancer and cardiovascular treatment, and medical diagnosis of cancer and cardiovascular diseases in the nature of dispensing of medical diagnostics and pharmaceutical and medical preparations containing magnetic particles; Physical therapy by conducting medical device-based therapeutic or diagnostic methods, namely, providing physical therapy using magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles containing iron oxide; medical services, namely, treatment of malignant or benign tumor diseases, cardiovascular diseases, arthritis, arthrosis, arteriosclerosis, stenosis, restenosis and/or skin diseases; medical services, namely, medical services in the nature of thermotherapeutic services, thermoablation methods and/or hyperthermia methods for cancer and cardiovascular treatment using magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles; providing medical testing for diagnostic or treatment purposes in the field of cancer and cardiovascular treatment; none of the foregoing services comprising radiotherapy in cancer treatment
Owner
- MagForce NT GmbH, Berlin, DE
- MagForce NT GmbH, Berlin, DE
Prosecution history
- 07 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2025 — SOU EXTENSION 2 GRANTED
- 06 Nov 2025 — SOU EXTENSION 2 FILED
- 06 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 19 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 May 2025 — SOU EXTENSION 1 GRANTED
- 19 May 2025 — SOU EXTENSION 1 FILED
- 19 May 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Sept 2024 — PUBLISHED FOR OPPOSITION
- 04 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Aug 2024 — EXAMINER'S AMENDMENT ENTERED
- 16 Aug 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED